JP3549643B2 - Medical substrate - Google Patents

Medical substrate Download PDF

Info

Publication number
JP3549643B2
JP3549643B2 JP23890995A JP23890995A JP3549643B2 JP 3549643 B2 JP3549643 B2 JP 3549643B2 JP 23890995 A JP23890995 A JP 23890995A JP 23890995 A JP23890995 A JP 23890995A JP 3549643 B2 JP3549643 B2 JP 3549643B2
Authority
JP
Japan
Prior art keywords
medical
container
propylene
random copolymer
copolymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP23890995A
Other languages
Japanese (ja)
Other versions
JPH0975444A (en
Inventor
修身 東雲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP23890995A priority Critical patent/JP3549643B2/en
Publication of JPH0975444A publication Critical patent/JPH0975444A/en
Application granted granted Critical
Publication of JP3549643B2 publication Critical patent/JP3549643B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

【0001】
【発明の属する技術分野】
本発明は、血液、輸液等医療分野において扱われる液体を収容・保存する容器、搬送するチューブ(連結管)等に適した軟質の医療用基材に関する。
【0002】
【従来の技術】
採血、輸血、輸液等の医療分野において用いられる容器やチューブの材料には安全性・衛生性の他、種々の性能が要求させるが、なかでも柔軟性、透明性、耐熱性(耐高圧蒸気滅菌性)およびこれらのバランスは重視される項目である。上記用途のポリマー素材としては従来から軟質ポリ塩化ビニルおよびエチレン酢酸ビニルコポリマー、低密度ポリエチレンの如きポリエチレン系ポリマーが代表例であるが、軟質ポリ塩化ビニルでは可塑剤の溶出、着色、廃棄処理などのおいて問題を生じることがある。ポリエチレン系の場合は柔軟性・透明性と耐熱性とのバランスに欠け、低密度品は柔軟性・透明性は比較的よいが、必然的に軟化点が低くなるので耐熱性が低下し、通常100〜121℃で行われる高圧蒸気滅菌に耐えられず、ブロッキング、失透(白化)、容器表面へのアバタ状のムラの発生、変形などを生じやすい。
【0003】
ポリプロピレンも医療容器用材料として広く使われているポリマーであり、一般的には耐熱性は十分であるが、高剛性であり(柔軟性に乏しく)、軟質化の工夫が必要である。軟質化の手段としては、▲1▼柔軟性のあるポリマー例えばオレフィン系エラストマーやスチレン系エラストマーのブレンド、▲2▼共重合が挙げられる。しかしながら、▲1▼は多量の柔軟剤の導入が必要であり、シート表面の粘着性増大によるブロッキングの問題の他、シート形成能低下による成形性・加工性の低下、柔軟剤の高価格などのため制限を受けやすい。▲2▼ではコモノマーとしてエチレンもしくはブテン−1を含むランダムコポリマーあるいはブロックコポリマーが代表例であり、特にランダムコポリマータイプは透明性にすぐれるという点で有利であるが、柔軟性を増すべくコモノマー成分の含量を増すと融点降下のため耐熱性が低下するばかりでなく、低分子量成分や無定形成分が多くなるので製品(容器)表面にべたつきの問題が生じる。一方、ブロックコポリマータイプでは耐衝撃性が増す利点があるが、透明性や柔軟性に劣る。また、クレージング(製品に応力を加えると、例えば曲げると、表面または内部に細かい割れが生じる現象)のため、製品の品位が低下する。
【0004】
【発明が解決しようとする課題】
本発明は従来技術の持つ上述の如き諸問題のうちのポリプロピレン系医療用基材の欠点を解消すべくなされたものである。
【0005】
【課題を解決するための手段】
本発明者の検討で明らかになったのは、ランダムとブロックのいわゆる「ハイブリッドコポリマー」タイプの適用が課題解決につながることであり、プロピレンを主成分とするランダムコポリマー(A)とプロピレン以外のα−オレフィンを主成分とするポリマー(B)とのブロックコポリマーを層成分として含む医療用基材を要旨とする本発明に至った。
【0006】
本発明の基材におけるポリマー(以下H−PPと称す)はポリプロピレン系ランダムコポリマーとポリプロピレン系ブロックコポリマーの特徴を兼備し、高圧蒸気滅菌処理しても良好な透明性と柔軟性が保持され、軟質ポリプロピレンにつきもののべたつきの問題もないので、性能バランスのとれた医療用の材料を提供する。
【0007】
【発明の実施の形態】
H−PPは通常公知の方法で製造され得る。まず、プロピレンとα−オレフィン(エチレン、ブテン−1、ヘキセン−1など)のランダムコポリマー(A)を重合し、次いでα−オレフィン(エチレン、ブテン−1、ヘキセン−1など)を添加して重合を続ける方法が一般的である。重合触媒としてはZiegler−Natta触媒が最も汎用的であり、場合によってはメタロセン触媒が使われる。立体規則性(アイソタクチックまたはシンジオタクチック)の度合、頭−頭結(尾−尾結合)の含量などにもよるが、本発明の医療容器用基材に適用されるH−PPはランダムコポリマー(A)中のプロピレン含量が90〜95モル%、ブロックコポリマー(すなわちH−PP)中のプロピレン含量が70〜85モル%であることがよい。ランダムコポリマー(A)中のプロピレン含量が少ないと柔軟性は増すが融点が低下し(耐熱性が低下し)、プロピレン以外のα−オレフィンを主成分とするポリマー(B)の含量が多いと柔軟性は増すがクレージング等好ましからぬ現象が生じることがある。そして、成形性、成形物の力学的性質などを考慮すると温度230℃、荷重2160gのおけるメルトフローレイト(MFR)が0.5〜20より好ましくは0.8〜15であるのがよい。
【0008】
以下、本発明におけるH−PPについて若干の補足説明を加える。
(1)ランダムコポリマー(A)とポリマー(B)におけるα−オレフィンは必ずしも同一であることを意味しない。すなわち(A)中のコモノマー(α−オレフィン)がエチレンであり、(B)を形成するモノマーがブテン−1であることもあり得る。
(2)ランダムコポリマー(A)におけるコモノマー(α−オレフィン)は必ずしも一種でなく、二種以上のこともあり得る。例えば、(A)がプロピレン−エチレン−ブテン−1の三元共重合体(ターポリマー)であることもある。
H−PPは通常(A)−(B)型(ジブロック型)であるがマルチブロックタイプ例えば(A)−(B)−(A)型(トリブロック型)であってもよい。
【0009】
冒頭に記載した如く、本発明の医療容器用基材は(A)と(B)とのブロックコポリマーを層成分として含むが、ここで「層成分として含む」とは、▲1▼基材が該ブロックコポリマー(H−PP)のみからなる場合と、▲2▼基材が該ブロックコポリマー(H−PP)を少なくとも一層とし他のポリマー(または重合体組成物)を少なくとも一層とする多層体からなる場合があるという意味である。▲2▼は容器の力学的性質(強度、耐ピンホール性など)、ガス透過性(酸素、炭酸ガス、水蒸気などの)、成形性、熱シール性などを調節・改良するために採用される。「他のポリマー」としてはポリエチレン、ポリブテン−1、ポリエステル、ポリアミド、エチレンビニルアルコールコポリマー、などの他、本発明におけるブロックコポリマー(H−PP)以外のポリプロピレン系ポリマー(ポリプロピレンホモポリマー、ポリプロピレンコポリマー)が挙げられるが、本発明の趣旨を生かすためには、これらのポリマーの層をできるだけ薄くするのが良いのは勿論である。
【0010】
なお、本発明におけるブロックコポリマー(H−PP)の透明性や柔軟性をさらに良くするための改質剤の添加を妨げるものではないことは言うまでもない。このような改質剤としては以下のようなエラストマーが適当であり、少量の添加(20重量%程度以下)で大きな効果がある(通常のポリプロピレンコポリマーの場合に比して少ない添加で済む)。
【0011】
(イ)オレフィン系熱可塑性エラストマー:エチレンとプロピレン、ブテン−1、ヘキセン−1などのα−オレフィン類のうち非晶性もしくは低結晶性のポリマーが好適であり、添加効果、成形性などを考慮すると、エチレン含有量が20〜80重量%より好ましくは25〜75重量%、MFR(温度230℃、荷重2160gで測定)が0.5〜15より好ましくは1〜10程度のものがよい。
【0012】
(ロ)スチレン系熱可塑性エラストマー:ブロック(ポリスチレン−エチレンブチレンコポリマー−ポリスチレン)(いわゆるSEBS)とブロック(ポリスチレン−エチレンプロピレンコポリマー−ポリスチレン)(いわゆるSEPS)が好適であり、ポリスチレン含有量が10〜60重量%より好ましくは15〜55重量%、MFR(温度230℃、荷重2160gで測定)が0.5〜20さらに好ましくは1〜15のものがよい。
【0013】
また、医療容器用基材の用途に要求される柔軟性、透明性、強度、ガスバリアー性あるいは単層体か多層体かによって異なるが、一般にはシートでは全体の厚さが好ましくは0.08〜1mmさらに好ましくは0.1〜0.8mm程度がよく、多層体の場合はブロックコポリマー(H−PP)層が全体の厚さの70%以上を占めるのがよい。チューブの場合では全体の厚さが0.3〜2.0mmさらに好ましくは0.5〜1.5mm程度がよく、複層チューブでは該ブロックコポリマー(H−PP)が全体の70%以上を占めるのがよい。
【0014】
本発明において医療容器とは赤血球、血小板、血漿などの血液成分、生理食塩水、電解質液、デキストラン製剤、マンニトール製剤、糖類製剤、アミノ酸製剤、脂肪乳剤などの輸液を収容・保存・搬送する容器やチューブを意味するが、このような製品は通常公知の方法で得られる。容器の場合は、単層もしくは多層用のTダイあるいはサーキュラーダイを介して押出し(溶融温度はポリマーの組合わせによって異なるが、好ましくは160〜250℃さらに好ましくは180〜230℃の範囲がよい)、得られたフラット状のシート、パリソンなどについて、ブロー、延伸、サーモフォーミング、裁断、融着(シール)などの手法を適宜活用して所定の形状・形態に加工すればよい。シートは無延伸物、延伸物いずれでもよいが、シール性を考えると無延伸物の方が好ましい。本発明の趣旨を損なわない範囲で、安定剤、着色剤、フィラー、スリップ剤などを添加したり、シート間のブロッキングを防ぐために容器の内面や外面を粗面化(エンボス加工)したりすることもできる。チューブの製造は通常の単層押出しあるいは多層押出しで行われ得る。
【0015】
本発明の医療容器用基材の応用例として、いわゆる「複室容器」がある。例えば輸液の場合、アミノ酸とブドウ糖とを含む液はメイラード反応による変質が起こりやすいので、各成分を別々の閉鎖系に保存しておき、患者への投与の直前に混合することが多いが、この際混合操作を無菌的に(クローズドシステム)行うために、また容易に操作するために、複数の収容室に区画された容器を用い、該収容室の各々に異なる輸液成分を保存しておき、使用直前に区画された収容室を何らかの手段でクローズドシステム内で連通させ混合する方法が実用化されるようになった。ここで使われる容器が複室容器であり、その一つの方式がイージリィピーラブルタイプである。すなわち収容空間の隔壁部のシールを比較的安定でかつ混合時(使用時)には容易に破断できる接着強度としたものである。技術的ポイントは製造時あるいは輸送時においては収容空間の隔壁シールが比較的安定で破断しにくく、使用時(混合時)には手、治具などで容易に破断され得る程度のシール強度を持つ一方、外界(大気)とつながる境界部(容器周縁部)はこれらの操作によって破断しない位の大きな強度を示すことである。したがって、容器を形成する材質の選定が重要となるのであるが、本発明の医療容器用基材はシール強度を調節しやすく、透明性、柔軟性も実用的な範囲にあるので、イージリィピーラブルタイプの複室容器用材料として向いている(以下の実施例にも示した)。
【0016】
【実施例】
以下実施例により本発明をさらに詳細に説明する。
(1)実施例1〜5、比較例1,2
(1−1)実験方法
▲1▼原料ポリマーの準備:使用したポリマーおよび重合体組成物(いずれもペレット状)を以下に示す。
:ランダムコポリマー(A)成分中のプロピレン含量が93モル%で、ブロックコポリマー中のプロピレン含量が85モル%のH−PP。コモノマーはブテン−1で、MFRは1.8。
:ランダムコポリマー(A)成分中のプロピレン含量が90モル%で、ブロックコポリマー中のプロピレン含量が77モル%のH−PP。コモノマーはエチレンで、MFRは2.2。
:ランダムコポリマー(A)成分中のプロピレン含量が95モル%で、ブロックコポリマー中のプロピレン含量が70モル%のH−PP。コモノマーはブテン−1で、MFRは2.0。
:プロピレン含量が85モル%のポリプロピレンランダムコポリマー。コモノマーはブテン−1で、MFRは1.9。
:プロピレン含量が77モル%のポリプロピレンブロックコポリマー。コモノマーはブテン−1で、MFRは2.3。
Z:プロピレン含量が95モル%のポリプロピレンランダムコポリマー。コモノマーはエチレンで、MFRは1.7。
S:XとSEBS(スチレン含有20重量%、MFR1.0)との重合体組成物(重量比90:10)。重合体組成物Sは、2軸溶融混合押出機を用いて溶融温度200℃で混練することによって得た。
【0017】
▲2▼シートの作製:上記▲1▼のポリマーまたは重合体組成物を適宜選択して、190〜210℃で溶融し、単層型または2種2層型のインフレダイから吐出させ(ブローアップ比1.2)、水冷リングで冷却後、5m/分の速度で巻取って、厚さ0.03mm,折径150mmのインフレシートを得た。シート構成を表1に示す。
▲3▼容器の作製:▲2▼で得られたシートを240mm長に裁断し、熱シールしてバッグを作製し、生理食塩水500mlを入れて密封した。
▲4▼高圧蒸気滅菌テスト:▲3▼で得られた生理食塩水入り容器をレトルト型高圧蒸気滅菌機に入れ、温度110℃、ゲージ圧1.8kg/cm、時間60分の条件で処理した。室温まで冷却後さらに3日間放置し、▲5▼および▲6▼の測定用サンプルとした。
▲5▼シート物性の測定:▲4▼の3日間放置後の容器シートを切り取り、波長450mmにおける水中透過率を島津ダブルビーム型自記分光光度計UV−300にて測定し、透明性の尺度とした。また、JISK7113に準じて引張弾性率を測定し、柔軟性の尺度とした。
▲6▼容器(シート)表面の調査:▲4▼の3日間放置後の容器表面のべたつき状態を肉眼観察するとともに、手でさわって調べた。
▲7▼表面のしわ試験:▲4▼の3日間放置後の容器のシート部分を指でつまみ(約3秒間)、放した後のしわの状態を観察し、クレージングの発生の程度を調べる試験の代用とした。
▲8▼溶出物試験:日本薬局方一般試験法「輸液用プラスチック容器試験法」に準じて、▲2▼で得られたシートについて試験した。
【0018】
(1−2)実験結果(表1参照)
【表1】

Figure 0003549643
【0019】
▲1▼シートの押出し成形は順調であり、いずれの組成においても、異物、発泡、ブロッキングなどは観察されず、均一なシートが得られた。
▲2▼実施例1〜5のシートの溶出物は、日本薬局方に適合することが観察された。
▲3▼表1から次のことが明らかである。
【0020】
(イ)ポリプロピレンを主成分とするランダムコポリマー(A)とポリエチレンもしくはポリブテン−1(B)とのブロックコポリマー(H−PP)を層成分として含むシートは透明性にすぐれており、柔軟性も(0.30mm程度の肉厚では)ソフトバックとして十分通用する。
(ロ)H−PPを層成分として含む容器(シート)は表面にべたつき現象が発生せず、しわ(クレージング)も問題にならない。
(ハ)単なるランダムコポリマーの場合(比較例1)には、透明性や柔軟性が良い領域ではシート表面にべたつきが発生しやすい(比較例2では容器表面が濡れていると感じられるほどのべたつき状態であった)。
(ニ)単なるブロックポリマーの場合(比較例2)には、透明性と柔軟性に劣る他、クレージングのために製品(容器)の品位に問題がある。
【0021】
(2)実施例6,7(複室容器への応用)
(2−1)実験方法
▲1▼複室容器の作製:実施例3および5で使ったインフレシートを350mm長に裁断し、中央部の幅7mmを温度120℃、圧力2kg/cm,時間5秒の条件で熱シール後、片方の室にアミノ酸3wt/V%水溶液、もう一方の室にブドウ糖15wt/V%水溶液各300mlを入れ、両端を幅10mm、温度160℃、圧力4kg/cm、時間5秒の条件で熱シールし、区画室が2個の薬液入り複室容器を作製した。それぞれを実施例6および7とする。
▲2▼高圧蒸気滅菌:▲1▼の容器を高圧蒸気滅菌機に入れ、窒素雰囲気下で、温度110℃、ゲージ圧1.8kg/cm、時間30分の条件において滅菌し、室温まで冷却した。
▲3▼シール強度の測定:▲2▼の容器を窒素雰囲気中で3〜5日放置した後、容器の中央部(仕切り部)および端部(周縁部)のシール部を切り取り、300mm/分の速度で180度剥離強度を測定し、15mm幅の時のシール強度に換算した。
▲4▼容器の仕切り部の破断性(連通性)の評価:5日間放置後の▲2▼の容器を机の上に寝かせて置き、一方の区画室側を手で押さえる程度で、仕切り部のシールが破断するか否かを確認した(各例につき5回テスト)。
【0022】
(2−2)実験結果
▲1▼シール強度:容器の仕切り部のシール強度は実施例6では0.4〜0.6kg/15mm、実施例7では0.5〜0.6kg/15mmであった。また周縁部のシール強度は実施例6,7ともに2.4〜2.6kg/15mmであった。
▲2▼容器の仕切り部の破断性(連結性):実施例6および実施例7ともに良好であり、容易に連通させることができた。上記▲1▼のシール強度のデータもこれを裏付けている。
【0023】
【発明の効果】
以上詳述した如く、本発明の医療容器用基材はプロピレンを主成分とするランダムコポリマー(A)とプロピレン以外のα−オレフィンを主成分とするブロックコポリマー(B)の特性を巧みに利用したものであり、透明性、柔軟性、耐熱性、外観などのバランスにすぐれている。また複室容器への応用も可能であり、生産性にも富むので、医療分野に有効に利用できる。[0001]
TECHNICAL FIELD OF THE INVENTION
The present invention relates to a soft medical base material suitable for a container for storing and storing a liquid handled in the medical field such as blood and infusion, and a tube (connecting tube) for transport.
[0002]
[Prior art]
Materials for containers and tubes used in medical fields such as blood collection, blood transfusion, and transfusion require safety, hygiene, and various other properties. Among them, flexibility, transparency, and heat resistance (high-pressure steam sterilization) Gender) and their balance are important items. Typical examples of the polymer material for the above applications include soft polyvinyl chloride and ethylene-vinyl acetate copolymer, and polyethylene polymers such as low-density polyethylene. May cause problems. In the case of polyethylene, the balance between flexibility / transparency and heat resistance is lacking.Low density products have relatively good flexibility / transparency, but inevitably have a lower softening point, resulting in lower heat resistance. It cannot withstand high-pressure steam sterilization performed at 100 to 121 ° C., and easily causes blocking, devitrification (whitening), generation of avatar-like unevenness on the container surface, and deformation.
[0003]
Polypropylene is also a polymer widely used as a material for medical containers, and generally has sufficient heat resistance, but has high rigidity (poor flexibility) and requires some softening. As means for softening, (1) a flexible polymer, for example, a blend of an olefin-based elastomer or a styrene-based elastomer, and (2) a copolymerization. However, (1) requires the introduction of a large amount of a softening agent, and in addition to the problem of blocking due to an increase in the stickiness of the sheet surface, a decrease in formability and workability due to a decrease in sheet forming ability, and a high cost of the softening agent. Due to restrictions. In the case of (2), a random copolymer or a block copolymer containing ethylene or butene-1 as a comonomer is a typical example. In particular, a random copolymer type is advantageous in that it has excellent transparency. When the content is increased, not only the heat resistance is lowered due to a decrease in melting point, but also a low molecular weight component and an amorphous component are increased, so that a problem of stickiness on a product (container) surface occurs. On the other hand, the block copolymer type has an advantage of increasing impact resistance, but is inferior in transparency and flexibility. Further, crazing (a phenomenon in which, when stress is applied to a product, for example, when it is bent, fine cracks are generated on the surface or inside), the quality of the product is reduced.
[0004]
[Problems to be solved by the invention]
The present invention has been made to solve the drawbacks of the polypropylene-based medical base material among the above-mentioned problems of the prior art.
[0005]
[Means for Solving the Problems]
What the inventors have found is that the application of the so-called “hybrid copolymer” type of random and block leads to the solution of the problem. The random copolymer (A) containing propylene as a main component and α other than propylene -The present invention has been made to provide a medical substrate including a block copolymer with a polymer (B) having an olefin as a main component as a layer component.
[0006]
The polymer (hereinafter referred to as H-PP) in the base material of the present invention has the characteristics of a polypropylene-based random copolymer and a polypropylene-based block copolymer, and has good transparency and flexibility even when subjected to high-pressure steam sterilization. The present invention provides a medical material with a well-balanced performance because there is no sticky problem inherent to polypropylene.
[0007]
BEST MODE FOR CARRYING OUT THE INVENTION
H-PP can be produced by a generally known method. First, a random copolymer (A) of propylene and an α-olefin (ethylene, butene-1, hexene-1, etc.) is polymerized, and then an α-olefin (ethylene, butene-1, hexene-1, etc.) is added and polymerized. The method of continuing is generally. As a polymerization catalyst, a Ziegler-Natta catalyst is most widely used, and in some cases, a metallocene catalyst is used. Although depending on the degree of stereoregularity (isotactic or syndiotactic) and the content of head-to-head connection (tail-to-tail bond), H-PP applied to the medical container base material of the present invention is random. It is preferable that the propylene content in the copolymer (A) is 90 to 95 mol%, and the propylene content in the block copolymer (i.e., H-PP) is 70 to 85 mol%. If the propylene content in the random copolymer (A) is low, the flexibility increases, but the melting point decreases (heat resistance decreases). If the content of the polymer (B) mainly composed of α-olefin other than propylene is large, the flexibility is increased. However, undesirable phenomena such as crazing may occur. In consideration of moldability, mechanical properties of the molded product, and the like, the melt flow rate (MFR) at a temperature of 230 ° C. and a load of 2160 g is preferably 0.5 to 20, more preferably 0.8 to 15.
[0008]
Hereinafter, some supplementary explanations will be added for the H-PP in the present invention.
(1) The α-olefin in the random copolymer (A) and the polymer (B) do not necessarily mean that they are the same. That is, the comonomer (α-olefin) in (A) may be ethylene, and the monomer forming (B) may be butene-1.
(2) The comonomer (α-olefin) in the random copolymer (A) is not necessarily one kind, but may be two or more kinds. For example, (A) may be a terpolymer of propylene-ethylene-butene-1 (terpolymer).
The H-PP is generally of the (A)-(B) type (diblock type), but may be of the multi-block type, for example, the (A)-(B)-(A) type (triblock type).
[0009]
As described at the beginning, the base material for a medical container of the present invention contains a block copolymer of (A) and (B) as a layer component. In the case where the block copolymer (H-PP) alone is used, and (2) the base material is composed of a multilayer body having at least one block copolymer (H-PP) and at least one other polymer (or polymer composition). It means that there may be cases. (2) is used to adjust and improve the mechanical properties (strength, pinhole resistance, etc.), gas permeability (of oxygen, carbon dioxide, water vapor, etc.), moldability, heat sealability, etc. of the container. . Examples of the "other polymer" include polyethylene, polybutene-1, polyester, polyamide, ethylene vinyl alcohol copolymer, and the like, and polypropylene-based polymers (polypropylene homopolymer and polypropylene copolymer) other than the block copolymer (H-PP) in the present invention. However, it is needless to say that in order to make use of the gist of the present invention, it is better to make these polymer layers as thin as possible.
[0010]
It goes without saying that addition of a modifier for further improving the transparency and flexibility of the block copolymer (H-PP) in the present invention is not prevented. As such a modifier, the following elastomers are suitable, and a small amount of addition (about 20% by weight or less) has a great effect (addition is small compared to the case of ordinary polypropylene copolymer).
[0011]
(A) Olefin-based thermoplastic elastomer: Among α-olefins such as ethylene and propylene, butene-1, hexene-1, etc., amorphous or low-crystalline polymers are suitable, and the effects of addition, moldability, etc. are taken into consideration. Then, the ethylene content is preferably from 20 to 80% by weight, more preferably from 25 to 75% by weight, and the MFR (measured at a temperature of 230 ° C. under a load of 2160 g) of from about 0.5 to 15, more preferably about 1 to 10.
[0012]
(B) Styrene-based thermoplastic elastomer: Block (polystyrene-ethylenebutylene copolymer-polystyrene) (so-called SEBS) and block (polystyrene-ethylene propylene copolymer-polystyrene) (so-called SEPS) are suitable, and the polystyrene content is 10 to 60. More preferably, the MFR (measured at a temperature of 230 ° C. under a load of 2160 g) is 0.5 to 20 and more preferably 1 to 15.
[0013]
In addition, although the thickness varies depending on the flexibility, transparency, strength, gas barrier property, or single-layer or multilayer structure required for the use of the medical container base material, the overall thickness of the sheet is preferably 0.08 or more. The thickness is preferably about 0.1 to 0.8 mm, and in the case of a multilayer body, the block copolymer (H-PP) layer preferably occupies 70% or more of the entire thickness. In the case of a tube, the total thickness is preferably 0.3 to 2.0 mm, more preferably about 0.5 to 1.5 mm, and in a multi-layer tube, the block copolymer (H-PP) accounts for 70% or more of the whole. Is good.
[0014]
In the present invention, the medical container is a container that stores, stores, and transports infusions such as red blood cells, platelets, blood components such as plasma, physiological saline, electrolyte solution, dextran preparation, mannitol preparation, saccharide preparation, amino acid preparation, and fat emulsion. Although it refers to a tube, such products are usually obtained by known methods. In the case of a container, it is extruded through a single-layer or multilayer T-die or a circular die (the melting temperature varies depending on the combination of polymers, but is preferably 160 to 250 ° C, more preferably 180 to 230 ° C). The obtained flat sheet, parison and the like may be processed into a predetermined shape and form by appropriately utilizing techniques such as blowing, stretching, thermoforming, cutting, and fusion (sealing). The sheet may be either a non-stretched product or a stretched product, but a non-stretched product is more preferable in consideration of sealing properties. Adding a stabilizer, a coloring agent, a filler, a slipping agent, and the like, or roughening (embossing) the inner and outer surfaces of the container to prevent blocking between sheets within a range that does not impair the purpose of the present invention. You can also. The production of the tube can be carried out by conventional single-layer extrusion or multilayer extrusion.
[0015]
As an application example of the medical container base material of the present invention, there is a so-called “multi-chamber container”. For example, in the case of infusion, a solution containing an amino acid and glucose is liable to deteriorate due to the Maillard reaction, so each component is stored in a separate closed system and often mixed immediately before administration to a patient. In order to perform the mixing operation aseptically (closed system) and to easily operate, using a container partitioned into a plurality of storage rooms, storing different infusion components in each of the storage rooms, A method has been put to practical use in which a storage room partitioned immediately before use is communicated by some means in a closed system and mixed. The container used here is a multi-chamber container, one of which is an easy peelable type. That is, the seal of the partition wall portion of the housing space is relatively stable and has an adhesive strength that can be easily broken at the time of mixing (at the time of use). The technical point is that the partition seal of the storage space is relatively stable and difficult to break during manufacturing or transportation, and has a seal strength that can be easily broken by hand or jig when used (at the time of mixing). On the other hand, the boundary part (peripheral part of the vessel) connected to the outside world (atmosphere) has such a large strength that it is not broken by these operations. Therefore, it is important to select a material for forming the container. However, the medical container base material of the present invention can easily adjust the sealing strength, and the transparency and flexibility are within a practical range. It is suitable as a material for a rubble type double chamber container (also shown in the following examples).
[0016]
【Example】
Hereinafter, the present invention will be described in more detail with reference to Examples.
(1) Examples 1 to 5, Comparative Examples 1 and 2
(1-1) Experimental method (1) Preparation of raw polymer: The used polymer and polymer composition (all in pellet form) are shown below.
X 1 : H-PP having a propylene content of 93 mol% in the random copolymer (A) component and a propylene content of 85 mol% in the block copolymer. The comonomer is butene-1 and the MFR is 1.8.
X 2 : H-PP in which the propylene content in the random copolymer (A) component is 90 mol% and the propylene content in the block copolymer is 77 mol%. The comonomer is ethylene with an MFR of 2.2.
X 3 : H-PP having a propylene content of 95 mol% in the random copolymer (A) component and a propylene content of 70 mol% in the block copolymer. The comonomer is butene-1 and the MFR is 2.0.
Y 1 : a polypropylene random copolymer having a propylene content of 85 mol%. The comonomer is butene-1 and the MFR is 1.9.
Y 2 : a polypropylene block copolymer having a propylene content of 77 mol%. The comonomer is butene-1 and the MFR is 2.3.
Z: a polypropylene random copolymer having a propylene content of 95 mol%. The comonomer is ethylene with an MFR of 1.7.
S: X 1 and SEBS (styrene content 20 wt%, MFR1.0) and the polymer composition (weight ratio 90:10). Polymer composition S was obtained by kneading at a melting temperature of 200 ° C. using a biaxial melt mixing extruder.
[0017]
(2) Preparation of sheet: The polymer or polymer composition of (1) is appropriately selected, melted at 190 to 210 ° C., and discharged from a single-layer or two-layer, two-layer inflation die (blow-up) After cooling with a water-cooled ring at a ratio of 1.2), the film was wound at a speed of 5 m / min to obtain an inflation sheet having a thickness of 0.03 mm and a folded diameter of 150 mm. Table 1 shows the sheet configuration.
(3) Preparation of container: The sheet obtained in (2) was cut into a length of 240 mm, heat-sealed to prepare a bag, and sealed with 500 ml of physiological saline.
(4) High-pressure steam sterilization test: The container containing the physiological saline obtained in (3) is put into a retort-type high-pressure steam sterilizer, and treated at a temperature of 110 ° C., a gauge pressure of 1.8 kg / cm 2 and a time of 60 minutes. did. After cooling to room temperature, the sample was allowed to stand for another 3 days to obtain a measurement sample for (5) and (6).
(5) Measurement of sheet physical properties: The container sheet left after standing for 3 days in (4) was cut out, and the transmittance in water at a wavelength of 450 mm was measured with a Shimadzu double beam type self-recording spectrophotometer UV-300. did. In addition, the tensile modulus was measured according to JIS K7113 and used as a measure of flexibility.
(6) Inspection of the surface of the container (sheet): The sticky state of the container surface after standing for 3 days in (4) was visually observed and touched by hand.
(7) Surface wrinkle test: A test for grasping the degree of crazing by grasping the sheet portion of the container after leaving it for 3 days in (4) with a finger (about 3 seconds), observing the state of the wrinkle after releasing, and examining the degree of crazing. Instead of
(8) Dissolution test: The sheet obtained in (2) was tested according to the Japanese Pharmacopoeia General Test Method "Test Method for Plastic Container for Infusion".
[0018]
(1-2) Experimental results (see Table 1)
[Table 1]
Figure 0003549643
[0019]
{Circle around (1)} The extrusion molding of the sheet was smooth, and no foreign matter, foaming, blocking, etc. were observed with any composition, and a uniform sheet was obtained.
{Circle around (2)} It was observed that the eluate of the sheets of Examples 1 to 5 conformed to the Japanese Pharmacopoeia.
(3) The following is clear from Table 1.
[0020]
(A) A sheet containing, as a layer component, a block copolymer (H-PP) of a random copolymer (A) mainly composed of polypropylene and polyethylene or polybutene-1 (B) is excellent in transparency and flexibility ( For a wall thickness of about 0.30 mm), it can be sufficiently used as a soft back.
(B) A container (sheet) containing H-PP as a layer component does not cause stickiness on its surface, and wrinkles (crazing) do not pose a problem.
(C) In the case of a simple random copolymer (Comparative Example 1), stickiness is likely to occur on the sheet surface in a region where transparency and flexibility are good (in Comparative Example 2, the container surface is so sticky that it feels wet). Condition).
(D) In the case of a simple block polymer (Comparative Example 2), transparency and flexibility are inferior, and there is a problem in the quality of a product (container) due to crazing.
[0021]
(2) Examples 6 and 7 (Application to a multi-chamber container)
(2-1) Experimental method (1) Preparation of multi-chamber container: The inflation sheet used in Examples 3 and 5 was cut into a length of 350 mm, and a width of 7 mm at the center was set to a temperature of 120 ° C., a pressure of 2 kg / cm 2 , and a time. After heat sealing under the condition of 5 seconds, a 3 wt / V% aqueous solution of amino acid and 300 ml of a 15 wt / V% aqueous solution of glucose were put in one chamber and the other chamber was 10 mm in width, both ends 10 mm in width, temperature 160 ° C., pressure 4 kg / cm 2. Heat sealing was performed for 5 seconds to prepare a multi-chamber container with two compartments. These are Examples 6 and 7, respectively.
(2) High-pressure steam sterilization: Put the container of (1) in a high-pressure steam sterilizer, sterilize it under a nitrogen atmosphere at a temperature of 110 ° C., a gauge pressure of 1.8 kg / cm 2 , and a time of 30 minutes, and cool to room temperature. did.
(3) Measurement of seal strength: After leaving the container of (2) in a nitrogen atmosphere for 3 to 5 days, the central part (partition part) and the end part (peripheral part) of the container were cut off, and 300 mm / min. The peeling strength was measured at a speed of 180 ° and converted to a sealing strength at a width of 15 mm.
(4) Evaluation of breakability (communication) of the partition part of the container: After leaving the container of (2) after standing for 5 days, lay it on a desk and hold down one of the compartments by hand. Was checked to see if the seal was broken (5 tests for each example).
[0022]
(2-2) Experimental results (1) Seal strength: The seal strength of the partition part of the container was 0.4 to 0.6 kg / 15 mm in Example 6, and 0.5 to 0.6 kg / 15 mm in Example 7. Was. In addition, the seal strength at the periphery was 2.4 to 2.6 kg / 15 mm in both Examples 6 and 7.
{Circle around (2)} Breakability (connectivity) of the partition part of the container: both Examples 6 and 7 were good and could be easily communicated. The data of the seal strength in (1) above supports this.
[0023]
【The invention's effect】
As described in detail above, the medical container base material of the present invention skillfully utilizes the properties of a random copolymer (A) containing propylene as a main component and a block copolymer (B) containing α-olefins other than propylene as a main component. It has a good balance of transparency, flexibility, heat resistance and appearance. It can also be applied to a multi-chamber container and has high productivity, so it can be effectively used in the medical field.

Claims (5)

プロピレンを主成分とするランダムコポリマー(A)とプロピレン以外のα−オレフィンを主成分とするポリマー(B)とのブロックコポリマーを層成分として含む医療用基材であって、前記ランダムコポリマー(A)がプロピレンとエチレンもしくはブテン−1とのランダムコポリマーであり、前記α−オレフィンを主成分とするポリマー(B)がポリエチレンまたはポリブテン−1であり、かつ、前記ランダムコポリマー(A)中のプロピレン含量が90〜95モル%であり、さらに、前記ブロックコポリマー中のプロピレン含量が70〜85モル%であることを特徴とする医療用基材。A medical substrate comprising, as a layer component, a block copolymer of a random copolymer (A) having propylene as a main component and a polymer (B) having an α-olefin other than propylene as a main component , wherein the random copolymer (A) Is a random copolymer of propylene and ethylene or butene-1, the polymer (B) having the α-olefin as a main component is polyethylene or polybutene-1, and the propylene content in the random copolymer (A) is 90 to 95 mol%, and the propylene content in the block copolymer is 70 to 85 mol% . 引張弾性率が3000kg/cm2以下である請求項1記載の医療用基材The medical substrate according to claim 1, having a tensile modulus of 3000 kg / cm 2 or less. 前記医療用基材は、医療容器用基材である請求項1に記載の医療用基材。The medical substrate according to claim 1, wherein the medical substrate is a medical container substrate. 前記医療用基材は、医療用複室容器用材料である請求項1に記載の医療用基材。The medical substrate according to claim 1, wherein the medical substrate is a material for a medical multi-chamber container. 前記医療用基材は、医療用複室容器用材料であり、かつ区画された収容空間の隔壁部のシールを安定でかつ混合時に容易に破断できる接着強度とするイージリィピーラブルタイプ用の複室容器用材料である請求項1に記載の医療用基材。The medical base material is a material for a medical multi-chamber container, and is a material for an easily removable type having an adhesive strength that can stably seal a partition portion of a partitioned storage space and easily break when mixed. The medical substrate according to claim 1, which is a material for a chamber container.
JP23890995A 1995-09-19 1995-09-19 Medical substrate Expired - Fee Related JP3549643B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23890995A JP3549643B2 (en) 1995-09-19 1995-09-19 Medical substrate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23890995A JP3549643B2 (en) 1995-09-19 1995-09-19 Medical substrate

Publications (2)

Publication Number Publication Date
JPH0975444A JPH0975444A (en) 1997-03-25
JP3549643B2 true JP3549643B2 (en) 2004-08-04

Family

ID=17037077

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23890995A Expired - Fee Related JP3549643B2 (en) 1995-09-19 1995-09-19 Medical substrate

Country Status (1)

Country Link
JP (1) JP3549643B2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4014688B2 (en) 1997-03-27 2007-11-28 株式会社不二工機 Expansion valve
US6303200B1 (en) * 1998-01-27 2001-10-16 Baxter International Inc. Low modulus and autoclavable monolayer medical tubing
JP4916609B2 (en) 2000-06-28 2012-04-18 藤森工業株式会社 Plastic film for medical liquid containers
JP2003052791A (en) * 2001-06-07 2003-02-25 Q P Corp Double cell container
JP4900583B2 (en) * 2006-11-21 2012-03-21 味の素株式会社 Medical multi-chamber container
JP5525847B2 (en) 2009-03-17 2014-06-18 日本ポリプロ株式会社 Propylene-based multilayer sheet and packaging bag for pressure treatment using the same
JP5636348B2 (en) 2010-09-14 2014-12-03 日本ポリプロ株式会社 Propylene-based resin multilayer sheet and package for heat treatment using the same
US20130177721A1 (en) 2010-09-17 2013-07-11 Japan Polypropylene Corporation Propylene resin sheet and heat processing packaging body using same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6092765A (en) * 1983-10-27 1985-05-24 テルモ株式会社 Medical instrument
JP2677920B2 (en) * 1990-10-25 1997-11-17 株式会社トクヤマ Propylene-ethylene / butene block copolymer and method for producing the same
JPH06171040A (en) * 1992-12-09 1994-06-21 Terumo Corp Polyolefin-based base material for medical container
JP3479163B2 (en) * 1995-06-26 2003-12-15 昭和電工株式会社 Polypropylene film and sheet

Also Published As

Publication number Publication date
JPH0975444A (en) 1997-03-25

Similar Documents

Publication Publication Date Title
JP5144573B2 (en) Polypropylene resin composition for medical containers and medical containers
JPH05293160A (en) Bag for medical treatment
JP3549643B2 (en) Medical substrate
JP2014180326A (en) Medical bag
JP5707260B2 (en) Plastic film and infusion bag
JP2000070331A (en) Medical partitioned case
JP3949739B2 (en) Medical multi-chamber container
RU2311165C2 (en) Medical container
JP6434844B2 (en) Medical multi-chamber container
JP3054426B2 (en) Medical bag
JPH0999036A (en) Vessel for medical treatment
JP3973703B2 (en) Medical multi-chamber container
JP3625497B2 (en) Medical container base material
JP5110672B2 (en) Blood component storage container
JP4016049B2 (en) Medical multi-chamber container
JPH10263071A (en) Base material for medical instrument and medical instrument
JPH08229099A (en) Medical double-chamber container
JPH0999037A (en) Double chamber vessel for medical treatment
JPH06171040A (en) Polyolefin-based base material for medical container
JPH0956778A (en) Multi-chamber vessel for medical use
JPH07125158A (en) Base material for medical vessel
JPH06169974A (en) Base material for polyolefin medical care container
JPH07164604A (en) Base material for medicare container
JPH0999035A (en) Vessel for medical treatment
JP2000197688A (en) Medical container

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040129

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20040129

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040420

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040421

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080430

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090430

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090430

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100430

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100430

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110430

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120430

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120430

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130430

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130430

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140430

Year of fee payment: 10

LAPS Cancellation because of no payment of annual fees